Science that walks
into the clinic.

Who we are

A clinical center jointly operated by EPFL, CHUV and UNIL.

We sit at the interface of fundamental neuroscience, implantable neurotechnology and early clinical translation. From the first experiment in the laboratory to the patient in the operating room, our teams design therapies that restore movement, balance and autonomy after neurological injury.

The center is co-directed by Prof. Grégoire Courtine (EPFL) and Prof. Jocelyne Bloch (CHUV / UNIL), and builds on more than fifteen years of preclinical work in rodent and non-human primate models.

Objectives

From rigorous preclinical studies to breakthrough treatments.

NeuroRestore integrates implantable neurotechnologies and innovative treatments resulting from rigorous preclinical studies conducted over the last fifteen years. These developments have led to breakthroughs for the treatment of paraplegia, tetraplegia, Parkinson’s disease, stroke and traumatic brain injuries.

Every technology we bring to the clinic starts in our preclinical laboratories at EPFL. There, we map the neurons that produce movement, design the implants that engage them, and test their safety and precision before any use in humans.